Skip to content

Respiratory Pathogen Distribution During and After the COVID-19 Pandemic

Comparative Analysis of Respiratory Pathogens During and After the SARS-CoV-2 Pandemic: A Retrospective Multiplex PCR-Based Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07601126
Enrollment
537
Registered
2026-05-22
Start date
2021-01-01
Completion date
2024-12-30
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Respiratory Infections, Viral Respiratory Infection (e.g., Influenza)

Keywords

Respiratory pathogens, Multiplex PCR, SARS-CoV-2, Pandemic period, Post-pandemic period

Brief summary

This retrospective observational study aims to evaluate changes in the prevalence and distribution of respiratory pathogens detected by multiplex respiratory polymerase chain reaction (PCR) testing during and after the SARS-CoV-2 pandemic. The study includes 537 patients presenting with respiratory infection symptoms at a tertiary care center. Patients were divided into pandemic-period and post-pandemic-period groups, and respiratory pathogen profiles were compared between the groups. The study investigates the epidemiological impact of COVID-19-related public health measures on respiratory pathogen circulation patterns, including bacterial and viral respiratory infections. The findings may contribute to improved respiratory infection surveillance, diagnostic strategies, and post-pandemic public health preparedness.

Detailed description

The COVID-19 pandemic significantly altered the epidemiology of respiratory infections worldwide. Non-pharmaceutical interventions (NPIs), including mask use, social distancing, travel restrictions, enhanced hygiene measures, and lockdown policies, were implemented primarily to reduce SARS-CoV-2 transmission. However, these interventions also affected the circulation patterns of other respiratory pathogens. Several studies have demonstrated substantial reductions in influenza, respiratory syncytial virus (RSV), and other respiratory viral infections during periods of strict public health measures. Following the relaxation of these interventions, many regions experienced re-emergence and altered seasonal patterns of respiratory pathogens. Continuous surveillance of respiratory infections has therefore become increasingly important for both clinical management and public health preparedness. This retrospective observational cohort study aims to evaluate changes in respiratory pathogen prevalence during and after the SARS-CoV-2 pandemic using multiplex respiratory PCR testing data obtained from patients presenting with respiratory infection symptoms at a tertiary care center. A total of 537 patients were included and categorized into pandemic-period and post-pandemic-period groups. Demographic characteristics and multiplex PCR results were analyzed and compared between the groups. Respiratory pathogens evaluated in the study included bacterial and viral agents such as Streptococcus pneumoniae, Haemophilus influenzae, Influenza A/B, SARS-CoV-2, RSV, Rhinovirus, Bocavirus, Parainfluenza virus, Coronavirus, and Metapneumovirus. The study aims to contribute to understanding the long-term epidemiological effects of the COVID-19 pandemic and associated public health measures on respiratory pathogen distribution. In addition, the findings may support future infection surveillance strategies, diagnostic approaches, and healthcare preparedness in post-pandemic periods.

Interventions

None listed

Sponsors

Hisar Intercontinental Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adults and/or pediatric patients presenting with respiratory infection symptoms * Patients who underwent multiplex respiratory PCR testing * Patients with complete demographic and laboratory records * Patients included during the defined pandemic or post-pandemic study periods

Exclusion criteria

* Incomplete laboratory or demographic data * Duplicate test records from the same infection episode * Invalid or inconclusive PCR results * Patients without respiratory infection symptoms

Design outcomes

Primary

MeasureTime frameDescription
Change in the prevalence of respiratory pathogens between the pandemic and post-pandemic periodsRetrospectively assessed at the time of respiratory PCR testing during the study periods. Pandemic period: March 2020 - May 2023 Post-pandemic period: June 2023 - December 202The primary outcome is the difference in detection rates of respiratory pathogens identified by multiplex respiratory PCR testing between the SARS-CoV-2 pandemic period and the post-pandemic period.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026